[Skip to Content]
[Skip to Content Landing]
JAMA Insights
Clinical Update
July 24/31, 2018

Long-acting Reversible Contraception—Highly Efficacious, Safe, and Underutilized

Author Affiliations
  • 1Department of Family Medicine, Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor
  • 2Department of Obstetrics and Gynecology, Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor
  • 3Department of Family Medicine, University of Michigan, Ann Arbor
JAMA. 2018;320(4):397-398. doi:10.1001/jama.2018.8877

Each year, 43 million women, nearly 70% of all reproductive-aged females in the United States, are at risk for unplanned pregnancy.1 These women are candidates for contraceptive counseling and services. Unplanned pregnancies are associated with increased risks of maternal and child morbidity and mortality and socioeconomic costs to families and society.2 Nearly half of all US pregnancies are unplanned.2 Increasing access to long-acting reversible contraception (LARC) is a critical strategy for decreasing the US rate of unplanned pregnancy.

×